Clinical Trials Logo

Clinical Trial Summary

This goal of this study is to evaluate an intensive group behavioral treatment (IGBT) program for children with selective mutism, a low base-rate childhood anxiety disorder. 29 children between the ages of 5 and 9 will be randomly assigned to participate in a 5-day IGBT over the summer or to a waitlist control condition, with the opportunity to participate in IGBT 4 weeks later. All children that participate in treatment will be followed up 8 weeks into the following school year.


Clinical Trial Description

n/a


Study Design


Related Conditions & MeSH terms


NCT number NCT03612102
Study type Interventional
Source Florida International University
Contact
Status Completed
Phase N/A
Start date February 11, 2017
Completion date December 14, 2017

See also
  Status Clinical Trial Phase
Completed NCT02554929 - Treatment of Social Anxiety Disorder and Selective Mutism N/A
Completed NCT00554749 - What Treatment Works for Children With Selective Mutism? N/A
Completed NCT04585048 - The Efficacy of Integrated Behavioral Therapy for Selective Mutism N/A
Completed NCT04291638 - Evaluating an Online Adjunctive Support Following Intensive Services (OASIS) Strategy for Youth With Selective Mutism N/A
Completed NCT01002196 - Randomised Controlled Treatment Study of Selective Mutism Phase 2
Completed NCT02009839 - Web-Based CBT Protocol for Treatment of Selective Mutism N/A
Recruiting NCT03528109 - Improving Access to Child Anxiety Treatment N/A
Completed NCT02051192 - Brief Behavioral Treatment for Anxiety in Young Children Phase 1/Phase 2
Completed NCT00458198 - Integrated Behavioral Therapy for Treating Children With Selective Mutism N/A
Completed NCT05378711 - Evaluating the Results of Physician and Parent Decisions to Treat Selective Mutism With Fluoxetine Phase 2
Completed NCT04233905 - Factors Influencing Selective Mutism